重度のうつ病に対する新しい治療法
Steven Marwaha1, Edward Palmer2, Trisha Suppes3
1Institute for Mental Health, University of Birmingham, Birmingham, UK; Birmingham and Solihull Mental Health NHS Trust, Birmingham, UK.
Lancet (London, England)
|December 19, 2022
まとめ
重度のうつ病に対する新しい生物学的治療法が 開発されています このレビューでは,新しい介入方法,そのメカニズム,および主要な公衆衛生問題であるうつ病の潜在的な臨床使用が評価されています.
科学分野:
- 神経科学
- 精神科
- 薬理学について
背景:
- 重度のうつ病 (MDD) は,公衆衛生と経済に重大な影響を及ぼす,蔓延し,衰弱させる状態です.
- MDDの現在の薬学的な治療には,遅い発症,一般的な副作用,そして多くの場合回復のために複数の治療薬が必要です.
- 中度から重度のうつ病の治療には より効果的な治療法が必要です
研究 の 目的:
- 重度のうつ病 (MDD) の新しい生物学的治療法を検討する.
- これらの新しい介入の基礎となる脳と体のメカニズムを評価する.
- これらの新興生物学的治療法の臨床的準備と広範な使用への接近性を評価する.
主な方法:
- 重度のうつ病に対する最近の治療試験の体系的なレビュー.
- 新しい生物学的介入に関する臨床前および臨床データの分析
- 神経生物学的および生理学的作用機構の評価
主要な成果:
- MDDに対するいくつかの有望な新しい生物学的治療法を特定した.
- これらの介入が対象となる脳と体のメカニズムを特徴づける.
- 現在の開発段階と臨床転用の可能性の評価
結論:
- 新興の生物学的治療法では 重度のうつ病の管理における満たされていないニーズに対処する見込みがある.
- 治療の有効性を最適化するために,特定の作用メカニズムを理解することは極めて重要です.
- これらの新しい治療法の安全性と有効性を確立するために,さらなる研究と臨床試験が必要である.
さらに関連する動画
05:19Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
2.4K
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
144
関連する概念動画
01:23Antidepressant Drugs: MAOIs and Other Agents
301
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
301
01:25Antidepressant Drugs: Overview
676
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
676
01:28Drug Therapy
83
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
83
01:24Treatment Strategies for Psychological Disorders
245
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
245
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
510
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
510
01:18Depression: Overview
317
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
317